Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

VTAKVTAK
2 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CATHETER PRECISION INC

No. Citadel Advisors exited its VTAK (Catheter Precision) position in Q1 2026. Its Q4 2025 13F listed 12,771 shares worth $23,371. Citadel Advisors first reported VTAK in Q4 2025 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$23,371

Total Shares Change

-12,771

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$1.55
0
2025-Q4
New
12,771
-
$23,3710.0%$1.56
29

Other major holders of VTAK: MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Virtu Financial LLC, UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used